Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,224 | 178,461 | 113,368 | 85,807 | 0 |
| Marketable Securities | 238,776 | 134,007 | 28,063 | 16,966 | 0 |
| Receivables | 7,214 | 3,682 | 32,023 | 7,385 | 0 |
| TOTAL | $307,729 | $324,323 | $176,079 | $111,900 | $0 |
| Non-Current Assets | |||||
| PPE Net | 4,144 | 4,029 | 4,201 | 4,079 | N/A |
| Other Non-Current Assets | 451 | 451 | 3,777 | 3,085 | 0 |
| TOTAL | $4,595 | $4,480 | $7,978 | $7,164 | $N/A |
| Total Assets | $312,324 | $328,803 | $184,057 | $119,064 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,140 | 2,483 | 2,532 | 1,250 | 0 |
| Accrued Expenses | 7,886 | 9,553 | 7,032 | 6,922 | 0 |
| TOTAL | $11,026 | $12,036 | $9,564 | $8,172 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 952 | 951 | 931 | 912 | 0 |
| TOTAL | $952 | $951 | $931 | $912 | $N/A |
| Total Liabilities | $11,978 | $12,987 | $10,495 | $9,084 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,480 | 35,444 | 1,906 | N/A | N/A |
| Common Shares | 3 | 3 | 1 | 1 | 0 |
| Retained earnings | -98,801 | -82,267 | -65,266 | -76,295 | 0 |
| Other shareholders' equity | -18 | -30 | 238,372 | 186,274 | 0 |
| TOTAL | $300,346 | $315,816 | $173,562 | $109,980 | $0 |
| Total Liabilities And Equity | $312,324 | $328,803 | $184,057 | $119,064 | $0 |